洁特生物: 关于增设募集资金专户并签署募集资金专户存储三方监管协议的公告

Summary of Key Points Core Viewpoint - The company has established a special account for the management and use of raised funds, ensuring investor protection and compliance with regulatory requirements [1][2][3]. Fundraising Basic Information - The company issued 4.4 million convertible bonds at a face value of 100 RMB each, raising a total of 440 million RMB, which has been verified by Tianjian Accounting Firm [1]. Special Account Establishment - A special account for raised funds has been set up to temporarily supplement working capital, with a limit of 200 million RMB, effective for up to 12 months from December 30, 2024 [2][3]. Three-Party Supervision Agreement - The company signed a three-party supervision agreement with the underwriter and the bank to regulate the management of raised funds, ensuring they are used solely for designated purposes [3][4]. Regulatory Compliance - The agreement aligns with relevant laws and regulations, including the Shanghai Stock Exchange's self-regulatory guidelines, to protect investor rights [4][5]. Monitoring and Reporting - The underwriter is responsible for ongoing supervision of the fund usage, including site investigations and documentation requests, to ensure compliance with the agreement [4][5].